Industry Focus Transcripts

Lessons to learn from one of the greatest bankers of our generation.

Precision medicines could take center stage at the market-moving cancer conference.

Will a new CEO fuel a turnaround for the No. 2 home improvement retailer?

Veeva's president discusses the cloud solution company he co-founded, from its small beginnings in healthcare CRM to its latest Vault products and expansion outside life sciences.

Technology is changing how doctors care for their patients.

Renewables are exciting, but long-term investors shouldn’t give up on fossil fuels for a few decades, at least.

Mass adoption of the internet reshaped the world in ways no one could have predicted. What do the next 25 years hold for technology?

Now that both rounds of the bank stress tests are over, let's review what we learned.

With Buffett’s 2016 annual letter now published, two Motley Fool analysts dig into its details.

Apparently Snap's IPO has a lot of people thinking about shorting stocks -- we answer a listener question and get into the nitty gritty risks of deciding to go short.

After its IPO, investors would be wise to let shares of Snap cool off before dipping their toes in.

A lot goes into determining how much a drug will cost, but its list price is far from the only thing investors need to know.

Exelixis, Pacira Pharmaceuticals, Kite Pharma, Exact Sciences, and Portola Pharmaceuticals are up more than 50% in the first two months of 2017.

Should I carry some debt on my credit card from month to month? Is trading on margin worth the risk if the rates are good? And more of your questions answered.

The tech company wants to go public, but there are quite a few red flags in its S-1 filing.

Dylan Lewis reports from Austin, Texas, at the SXSW conference, where he attended a session on the future of the payments industry. Tune in to hear more about the relationship between social media and existing payment processors as well as what the space might look like going forward.

The company has stumbled recently, but it has generally been strong.

The chain experienced some sales-volume drop due to seasonality.

GE is at a crossroads, and plenty are wary. But this trough could turn out to be a fantastic buying opportunity for the long term.

Universal Display had a wild year, but the company's future seems bright -- with a few key caveats.